2011

1) Albert ML, Casrouge A, Chevaliez S, Hezode C, Rosa I, Renard P, Mallet V, Fontanet A, Pawlotsky JM, Pol S. Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype. Hepatology. 2011; 53(4): 1410-1. Abstract

2) Buckwalter MR, Nga PT, Gouilh MA, Fiette L, Bureau JF, Laird ME, Buchrieser J, Ozden S, Cheval J, Eloit M, Manuguerra JC, Gessain A, Brey PT, Fontanet A, Albert ML. Identification of a Novel Neuropathogenic Theiler's Murine Encephalomyelitis Virus. J Virol. 2011; Jul;85(14): 6893-905. Abstract

3) Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest. 2011 4; 121(1): 308-17. Abstract

4) Chartier L, Leng C, Sire JM, Le Minor O, Saman M, Bercion R, Rahalison L, Fontanet A, Germany Y, L'Her P, Mayaud C, Vray M. Factors Associated with Negative Direct Sputum Examination in Asian and African HIV-Infected Patients with Tuberculosis (ANRS 1260). PLoS One. 6(6): e21212. Abstract

5) Deuffic-Burban S, Delarocque-Astagneau E, Abiteboul D, Bouvet E, Yazdanpanah Y. Blood-borne viruses in health care workers: Prevention and management. J Clin Virol 2011 Sep;52(1):4-10. Abstract

6) Garenne M, McCaa R, Nacro K . Maternal Mortality in South Africa: an update from the 2007 Community Survey. Journal of population Research 2011; 28(1):89-101. Abstract

7) Giles-Vernick T, Traore A, Sirima SB. Malaria, environmental change, and an historical epidemiology of childhood 'cold fevers': popular interpretations from southwestern Burkina Faso. Health & Place 2011; 17(3): 836-42. Abstract

8) Landier J, Akonde A, Pizzocolo C, Haidara I, Drabo M, Pizarro L, Fontanet A, Katlama C, Madec Y. Switch to second-line ART in West African routine care: incidence and reasons for switching. AIDS Care 2011 Nov; 23(1): 75-8. Abstract

9) Leroy S, Gervaix A. Procalcitonin: a key marker in children with urinary tract infection. Adv Urol; 2011: 397618. Abstract

10) Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother. 2011; 55(2): 532-8. Abstract

11) Marion E, Landier J, Boisier P, Marsollier L, Fontanet A, Le Gall P, Aubry J, Djeunga N, Umboock A, Eyangoh S. Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis. 2011; 17(3): 551-3. Abstract

12) Ostertag A, Cohen-Solal M, Madec Y, Baudoin C, de Vernejoul MC. Bone changes in spouses having shared lifestyle for 40 years. Joint Bone Spine. 2011; 78(3): 285-90. Abstract

13) Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, Kendjo E, Houze S, Le Bras J, Danis M, Durand R. Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2011; 17(5): 807-13. Abstract 14) Vignier N, Esmat G, Sharkawy AE, Hassany M, Bonnard P, Delarocque-Astagneau E, Said M, Raafat R, El-Hoseiny M, Fontanet A, Mohamed MK, Vray M. Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt. J Viral Hepat ; 18(7): e358-e365. Abstract

15) Guenin-Macé L, Carrette F, Asperti-Boursin F, Le Bon A, Caleechurn L, Di Bartolo V, Fontanet A, Bismuth G, Demangel C. Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12833-8. Epub 2011 Jul 18. Abstract

16) Madec Y, Germanaud D, Moya-Alvarez V, Alkassoum W, Issa A, Amadou M, Tchiombiano S, Pizzocolo C, Huber F, Diallo S, Abdoulaye-Mamadou R. HIV Prevalence and Impact on Renutrition in Children Hospitalised for Severe Malnutrition in Niger: An Argument for More Systematic Screening. PLoS One. 2011;6(7):e22787. Epub 2011 Jul 28. Abstract

17) Mbaye PS, Sarr A, Sire JM, Evra ML, Ba A, Daveiga J, Diallo A, Fall F, Chartier L, Simon F, Vray M. Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load. PLoS One. 2011;6(7):e22291. Epub 2011 Jul 25. Abstract

18) Porcher R, Lecocq B, Vray M; participants of Round Table N° 2 of Giens XXVI. Adaptive Methods: When and How Should They be Used in Clinical Trials? Therapie. 2011 Jul-Aug;66(4):319-26. Epub 2011 Aug 19. Abstract

19) Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE for the CAMELIA (ANRS 1295-CIPRA KH 001) study team. Earlier vs later start of antiretrovirals in adults with AIDS and tuberculosis. New Engl J Med 2011; 365:1471-1481. Abstract

20) Chauty A, Ardant MF, Marsollier L, Pluschke G, Landier J, Adeye A, Goundoté A, Cottin J, Ladikpo T, Ruf T, Ji B. Oral treatment for Mycobacterium ulcerans ulcerans infection: results from a pilot study in Benin. Clin Infect Dis. 2011; 52(1):94-6. Abstract

21) Sire JM, Vray M, Merzouk M, Plantier JC, Pavie J, Maylin S, Timsit J, Lascoux-Combe C, Molina JM, Simon F, Delaugerre C. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr. 2011 Mar; 56(3):239-43.
Abstract

22) Breban R. Health newscasts for increasing influenza vaccination coverage: an inductive reasoning game approach. PLoS One. 2011;6(12):e28300. Epub 2011 Dec 21. Abstract

23) Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, Izopet J, Mohamed MK, Fontanet A, Abdel Hamid M. Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. Clin Microbiol Infect. 2011 Nov 16. doi: 10.1111/j.1469-0691.2011.03727.x. [Epub ahead of print]. Abstract

24) Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 2011 Oct;7(10):e1002322. Abstract

25) Garenne M. Testing for fertility stalls in demographic and health survey. Popul Health Metr. 2011 Dec 8;9(1):59. Abstract

26) Garenne M. Estimating Obstetric Mortality from Pregnancy-Related Deaths Recorded in Demographic Censuses and Surveys. Stud Fam Plann. 2011 Dec;42(4):237-46. Abstract

27) Garenne M. The impact of HIV/AIDS on the Health Transition Among Under-Five Children in Africa. In: "AIDS", 2011 In-Tech Publishers. Abstract

28) Garenne M. Debate: Variation of human sex ratio at birth by the sex combinations of the existing sibs, and by reproductive stopping rules: answer to comments by William H. James. Abstract

29) Landier J, Boisier P, Fotso Piam F, Noumen-Djeunga B, Simé J, Wantong FG, Marsollier L, Fontanet A, Eyangoh S. Adequate wound care and use of bed nets as protective factors against Burulli Ulcer :  results from a case control study in Cameroon. PLoS Negl Trop Dis. 2011 Nov;5(11):e1392. Abstract

30) Bouvier I, Jusforgues-Saklani H, Lim A, Lemaître F, Lemercier B, Auriau C, Nicola MA, Leroy S, Law HK, Bandeira A, Moon JJ, Bousso P, Albert ML. Immunization route dictates cross-priming efficiency and impacts the timing of adjuvant delivery. Frontiers in Immunology 2011;2:1-18. [Epub ahead of print Dec 1]. Abstract

31) Lazaro E, Tram LT, Bellecave P, Guidicelli GL, Anies G, Thu HH, Debelleix MP, Vray M, Recordon-Pinson P, Taupin JL, Lien TT, Fleury H. Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159). PLoS One. 2011;6(10):e26244. Epub 2011 Oct 19. Abstract

32) Gergely AE, Bechet S, De Fanti AS, Le Guern AS, Goujon C, Pelicot M, Benabdelmoumen G, Consigny PH . Hepatitis A seroprevalence in a population of immigrants at a french vaccination center. J Travel Med. 2011 Mar-Apr;18(2):126-9. Abstract

33) Saliba G, Kamouh W, Fontanet A, Le Bras J. Predictive factors of severe disease secondary to falciparum malaria among travellers. Pathol Biol, 2011 Aug;59(4):230-3. Abstract

34) Vanhomwegen J, Kwara A, Martin M, Gillani FS, Fontanet A, Mutungi P, Crellin J, Obaro S, Gosciminski M, Carter EJ, Rastogi N. Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island. J Clin Microbiol. 2011 Mar;49(3):834-44. Abstract

R. Breban. Progress in low-dimensional chaos: On phase synchronization and indeterminate bifurcations. Lambert Academic Publishing, Saarbrucken.

Mis à jour le 12/06/2014

Contact

Unité d'Epidémiologie des Maladies Emergentes


Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15


Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 7

Email: ueme@pasteur.fr

Où nous trouver ?

plan.jpg

Agenda

Tout l'agenda